P. Andrew Futreal
0000-0001-8663-2671
Publication & Citation Trends
Publications
0 total
PP01.23/OA07.01: Myeloid IL-1 Signaling Drives The Precancer-to-Cancer Evolution of Human Pulmonary Nodules
Cited by 0
Semantic Scholar
Intratumoral microbiome of adenoid cystic carcinomas and comparison with other head and neck cancers OA
Cited by 5
Semantic Scholar
Multiregional transcriptomic profiling provides improved prognostic insight in localized non-small cell lung cancer OA
Cited by 3
Semantic Scholar
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Cited by 44
Semantic Scholar
ANPEP/CD13 Expression as Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma.
Cited by 2
Semantic Scholar
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma. OA
Cited by 111
Semantic Scholar
COSMIC: the catalogue of somatic mutations in cancer OA
Cited by 450
Semantic Scholar
CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes OA
Cited by 116
Semantic Scholar
Feedback Circuit among INK4 Tumor Suppressors Constrains Human Glioblastoma Development OA
Cited by 132
Semantic Scholar
Familial breast-ovarian cancer syndromes: BRCA1 and BRCA2.
Cited by 20
Semantic Scholar
Research Topics
Cancer Genomics and Diagnostics
(378)
Cancer Immunotherapy and Biomarkers
(180)
Acute Myeloid Leukemia Research
(136)
Lung Cancer Treatments and Mutations
(93)
CAR-T cell therapy research
(91)
Affiliations
Broad Institute
University of East Anglia
Ontario Institute for Cancer Research
University of North Carolina at Chapel Hill
Gynecologic Oncology Group